These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16466109)

  • 1. The role of inflammation in diabetes and its complications.
    Rizvi AA
    South Med J; 2006 Jan; 99(1):8-9. PubMed ID: 16466109
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes.
    Shab-Bidar S; Neyestani TR; Djazayery A; Eshraghian MR; Houshiarrad A; Kalayi A; Shariatzadeh N; Khalaji N; Gharavi A
    Diabetes Metab Res Rev; 2012 Jul; 28(5):424-30. PubMed ID: 22344966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum high sensitivity C-reactive protein, nitric oxide metabolites, plasma fibrinogen, and lipid parameters in Indian type 2 diabetic males.
    Sarangi R; Padhi S; Mohapatra S; Swain S; Padhy RK; Mandal MK; Patro SK; Kumar S
    Diabetes Metab Syndr; 2012; 6(1):9-14. PubMed ID: 23014248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects of air temperature on blood markers of coagulation and inflammation in potentially susceptible individuals.
    Schäuble CL; Hampel R; Breitner S; Rückerl R; Phipps R; Diaz-Sanchez D; Devlin RB; Carter JD; Soukup J; Silbajoris R; Dailey L; Koenig W; Cyrys J; Geruschkat U; Belcredi P; Kraus U; Peters A; Schneider AE
    Occup Environ Med; 2012 Sep; 69(9):670-8. PubMed ID: 22833664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and type 2 diabetes.
    Calle MC; Fernandez ML
    Diabetes Metab; 2012 Jun; 38(3):183-91. PubMed ID: 22252015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K; Matsumoto S; Aso Y; Inukai T
    J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoprotegerin and biomarkers of vascular inflammation in type 2 diabetes.
    O'Sullivan EP; Ashley DT; Davenport C; Devlin N; Crowley R; Agha A; Thompson CJ; O'Gorman D; Smith D
    Diabetes Metab Res Rev; 2010 Sep; 26(6):496-502. PubMed ID: 20809534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased variation of inflammatory markers in gestational diabetes.
    Pöyhönen-Alho M; Ebeling P; Saarinen A; Kaaja R
    Diabetes Metab Res Rev; 2011 Mar; 27(3):269-76. PubMed ID: 21309051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in inflammatory cardiovascular risk markers in hyperlipidemic diabetic patients treated with fenofibrate.
    Wu TJ; Ou HY; Chou CW; Hsiao SH; Lin CY; Kao PC
    Ann Clin Lab Sci; 2007; 37(2):158-66. PubMed ID: 17522372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of freeze-dried strawberry supplementation on metabolic biomarkers of atherosclerosis in subjects with type 2 diabetes: a randomized double-blind controlled trial.
    Moazen S; Amani R; Homayouni Rad A; Shahbazian H; Ahmadi K; Taha Jalali M
    Ann Nutr Metab; 2013; 63(3):256-64. PubMed ID: 24334868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, the metabolic syndrome and cardiovascular risk.
    Tracy RP
    Int J Clin Pract Suppl; 2003 Mar; (134):10-7. PubMed ID: 12793593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-grade systemic inflammation profile, unrelated to homocysteinemia, in obese children.
    Economou EV; Malamitsi-Puchner AV; Pitsavos CP; Kouskouni EE; Magaziotou-Elefsinioti I; Creatsas G
    Mediators Inflamm; 2005 Dec; 2005(6):337-42. PubMed ID: 16489253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes.
    Altinova AE; Toruner F; Akturk M; Bukan N; Yetkin I; Cakir N; Arslan M
    Scand J Clin Lab Invest; 2011 Jul; 71(4):340-3. PubMed ID: 21486111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis.
    Ranjit N; Diez-Roux AV; Shea S; Cushman M; Seeman T; Jackson SA; Ni H
    Arch Intern Med; 2007 Jan; 167(2):174-81. PubMed ID: 17242319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lipid and inflammatory markers with C-reactive protein in cardiovascular risk assessment for primary prevention.
    Jovicić S; Ignjatović S; Dajak M; Kangrga R; Majkić-Singh N
    Clin Lab; 2009; 55(11-12):411-9. PubMed ID: 20225663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes.
    Corrado E; Rizzo M; Muratori I; Coppola G; Novo S
    Arch Med Res; 2006 Nov; 37(8):1004-9. PubMed ID: 17045118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do your heart a favor: eat fish.
    Health News; 2005 Oct; 11(10):9. PubMed ID: 16252355
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes.
    Ramachandran S; Kartha CC
    Can J Physiol Pharmacol; 2012 Aug; 90(8):1005-15. PubMed ID: 22647032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NASH and cardiovascular biomarkers.
    Ercin CN; Dogru T; Tasci I; Erdem G; Sonmez A; Tapan S
    Obesity (Silver Spring); 2009 Apr; 17(4):627; author reply 627. PubMed ID: 19322144
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents.
    Syrenicz A; Garanty-Bogacka B; Syrenicz M; Gebala A; Walczak M
    Neuro Endocrinol Lett; 2006 Aug; 27(4):453-8. PubMed ID: 16892000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.